Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients*-Reference-Cited by-同舟云学术

Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients*

Published:2012-05-15 Issue:2 Volume:4 Page:181-185
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:

Author:

BUNCK Mathijs C.,POELMA Marieke,EEKHOFF E. Marelise,SCHWEIZER Anja,HEINE Robert J.,NIJPELS Giel,FOLEY James E.,DIAMANT Michaela

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1753-0407.2011.00168.x/fullpdf

Reference11 articles.

1. Potential role of pancreatic and enteric hormones in regulating bone turnover;Clowes;J Bone Miner Res,2005

2. Feeding and bone;Walsh;Arch Biochem Biophys,2010

3. Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor;Nuche Berenguer;J Cell Physiol,2010

4. Beta-cell function and glycemic control following one-year vildagliptin treatment, and after 12-week washout, in drug-naive patients with type 2 diabetes and mild hyperglycemia;Bunck;Diabetologia.,2011

5. Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women;Greenspan;J Clin Endocrinol Metab,2000

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis;Frontiers in Pharmacology;2024-04-25

2. Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD): Insight into Clinical Challenges in the Treatment of Type 2 Diabetes;Journal of Clinical Medicine;2023-11-23

3. Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes—A Systematic Review;JBMR Plus;2023-09-25

4. Gemigliptin attenuates reducing sugar-induced oxidative damage in MC3T3-E1 osteoblasts and improves osteoblastic differentiation;Life Cycle;2023-07-13

5. Gemigliptin attenuates reducing sugar-induced oxidative damage in MC3T3-E1 osteoblasts and improves osteoblastic differentiation;Life Cycle;2023-07-13